Jeffrey S. Glenn's Insider Trades & SAST Disclosures

Jeffrey S. Glenn's most recent trade in Eiger BioPharmaceuticals Inc was a trade of 28,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on March 1, 2023.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Eiger BioPharmaceuticals Inc
Jeffrey S Glenn Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Mar 2023 28,000 28,000 - - Stock Option (Right to Buy)
Eiger BioPharmaceuticals Inc
Jeffrey S Glenn Director Purchase of securities on an exchange or from another person at price $ 1.28 per share. 22 Dec 2022 100,000 182,355 (0%) 0% 1.3 127,950 Common Stock
Eiger BioPharmaceuticals Inc
Jeffrey S Glenn Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Mar 2021 10,000 10,000 - - Stock Option (Right to Buy)
Eiger BioPharmaceuticals Inc
Jeffrey S Glenn Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Mar 2021 5,000 76,355 (0%) 0% 0 Common Stock
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades